Rice Hall James & Associates’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-46,749
Closed -$2.77M 311
2021
Q4
$2.77M Buy
46,749
+15,203
+48% +$1.05M 0.1% 186
2021
Q3
$2.1M Sell
31,546
-277
-0.9% -$17.1K 0.08% 197
2021
Q2
$2.01M Sell
31,823
-1,155
-4% -$65K 0.07% 218
2021
Q1
$1.72M Sell
32,978
-37
-0.1% -$2.25K 0.06% 231
2020
Q4
$1.45M Sell
33,015
-1,340
-4% -$63.8K 0.05% 227
2020
Q3
$1.63M Sell
34,355
-26,943
-44% -$1.09M 0.07% 192
2020
Q2
$1.85M Sell
61,298
-24,361
-28% -$542K 0.08% 153
2020
Q1
$1.46M Sell
85,659
-25,261
-23% -$442K 0.08% 168
2019
Q4
$1.83M Sell
110,920
-3,185
-3% -$47.4K 0.06% 178
2019
Q3
$1.87M Sell
114,105
-6,137
-5% -$123K 0.07% 178
2019
Q2
$2.2M Sell
120,242
-56,310
-32% -$894K 0.07% 165
2019
Q1
$2.28M Sell
176,552
-7,703
-4% -$83.7K 0.07% 168
2018
Q4
$2.03M Buy
184,255
+81,459
+79% +$885K 0.07% 163
2018
Q3
$1.32M Sell
102,796
-24,171
-19% -$345K 0.05% 236
2018
Q2
$2M Buy
126,967
+44,599
+54% +$475K 0.07% 202
2018
Q1
$708K Buy
+82,368
New +$728K 0.03% 254

Other funds holding CYRX

Rice Hall James & Associates's CYRX Position: Q1 2022 in Review

Rice Hall James & Associates sold out of CryoPort (CYRX) in Q1 2022, closing a stake of 46,749 shares — an estimated $2.77M sold.

Rice Hall James & Associates first reported a position in CYRX in Q1 2018 and held it in 16 quarters. The position peaked at $2.77M in Q4 2021. 200 funds tracked by Wall St. Rank hold CYRX as of Q1 2022.

  • Rice Hall James & Associates reported no remaining CryoPort position as of Q1 2022 after selling out during the quarter.
  • Rice Hall James & Associates sold 46,749 CryoPort shares in Q1 2022, an estimated $2.77M.
  • Rice Hall James & Associates first reported a position in CryoPort in Q1 2018 and held it in 16 quarters.
  • Rice Hall James & Associates's CryoPort position peaked at $2.77M in Q4 2021.
  • 200 funds tracked by Wall St. Rank held CryoPort as of Q1 2022.

Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.